ישראל -
עברית -
Ministry of Health
יינטריב 40 מג
eli lilly israel ltd, israel - duloxetine as hydrochloride - קפסולות - duloxetine as hydrochloride 40 mg - duloxetine - duloxetine - yentreve is indicated for women for the treatment of moderate to severe stress urinary incontinence (sui).
ישראל -
עברית -
Ministry of Health
אגיסטן בייבי
padagis israel pharmaceuticals ltd, israel - clotrimazole - פסטה - clotrimazole 1 % - imidazole and triazole derivatives - for treatment of fungal nappy rash in children, that lasts over 72 hours.
ישראל -
עברית -
Ministry of Health
יומירה 40 מ"ג
abbvie biopharmaceuticals ltd, israel - adalimumab 40 mg / 0.8 ml - solution for injection - pfs - adalimumab - * rheumatoid arthritis: humira in combination with methotrexate is indicated for: - the treatment of moderate to severe active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate. - the treatment of severe active and progressive rheumatoid arthritis in adults not previously treated with methotrexate. humira can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate. humira has been shown to reduce the rate of progression of joint damage as measured by x-ray adn to impove physical function when given in combination with methotrexate. * crohn's disease : humira is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active crohn's disease who have had an inadequate response to conventional therapy.humira is indicated for reducing signs and symptoms and inducing clinical r
ישראל -
עברית -
Ministry of Health
יומירה 40 מ"ג
abbvie biopharmaceuticals ltd, israel - adalimumab 40 mg / 0.8 ml - solution for injection - vial - adalimumab - * rheumatoid arthritis: humira in combination with methotrexate is indicated for: - the treatment of moderate to severe active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drugs including methotrexate has been inadequate. - the treatment of severe active and progressive rheumatoid arthritis in adults not previously treated with methotrexate. humira can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate. humira has been shown to reduce the rate of progression of joint damage as measured by x-ray adn to impove physical function when given in combination with methotrexate. * crohn's disease : humira is indicated for reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active crohn's disease who have had an inadequate response to conventional therapy.humira is indicated for reducing signs and symptoms and inducing clinical r
ישראל -
עברית -
Ministry of Health
מונפלטין די אס אם - קרם לתינוק למניעת תפרחת חיתולים
א.משי - מניעת תפרחת חיתולים
ישראל -
עברית -
Ministry of Health
קר אנד ביוטי - קרם לתינוק למניעת תפרחת חיתולים
א.משי - מניעת תפרחת חיתולים
ישראל -
עברית -
Ministry of Health
וולדה - קרם קלנדולה לאזור החיתול
דר סמואלוב יבוא ושיווק בעמ - מניעת תפרחת חיתולים